Q4 2022 Essentials for Plan Sponsors
Here are some key factors and deadlines to keep in mind for Q4 2022.
December 27, 2022 – Prescription Drug Data Collection (RxDC) Reporting Is Due
The RxDC reporting requirement requires employers to submit prescription drug data to the Department of Health and Human Services (HHS), the Department of Treasury, and the Department of Labor (DOL). The deadline is December 27, 2022. Some of the required information includes:
- Most frequently dispensed drugs
- Â Most expensive medication
- Â Drugs that have registered the highest increase in cost.
Detailed reporting instructions are available from the Centers for Medicare and Medicaid Services, which is collecting the data.
HDHP Insulin Coverage
The Inflation Reduction Act of 2022 made changes to Section 223 of the IRS Code that affects High Deductible Health Plans (HDHPs). Specifically, an exception was added regarding insulin where beginning January 1, 2023, HDHPs will no longer need to meet the deductible before providing insulin coverage.
Contraceptive Coverage
On July 28, 2022, DOL, Treasury and HHS issued FAQs regarding implementing the Affordable Care Act. They included the contraceptive coverage mandate for non-grandfathered group health plans and insurers. The document confirms the mandate, clarifies rules on how coverage should be managed medically, and discusses enforcement strategies, among others.
The document also confirms that OTC contraception not covered by a health plan can be reimbursed from HSAs, health reimbursement arrangements, and health flexible spending accounts.
CARES Act and Relief Act Amendments Delayed
As of September 26, 2022, the deadline for implementing the amendments laid out by the Coronavirus Aid, Relief, and Economic Security (CARES) Act and the Taxpayer Certainty and Disaster Tax Relief (Relief) Act has been postponed until December 31, 2025.
For more Employee Benefits information, contact INSURICA today.
Copyright © 2022 Smarts Publishing
About the Author
Share This Story
Related Blogs
Trump Administration Reshapes Health Plan Oversight
The Trump administration has issued a series of executive orders aimed at recalibrating federal oversight of employer-sponsored health plans. These directives target unpublished rules and agency enforcement priorities, signaling a shift toward deregulation and increased flexibility for plan sponsors.
Compliance Update: Gag Clause Attestations, Contraceptive Coverage Ruling, and SF Ordinance Impacts
As Q4 begins, benefits managers face a trio of compliance developments with implications for plan design, documentation, and year-end filings. Two are federal in scope, while one local ordinance continues to affect employers nationwide.
Benefits Administration Update: MLR Rebates, Texas SB 1332, and Year-End Priorities
As the final quarter of 2025 begins, several developments in benefits administration are reshaping how employers manage compliance, coverage, and communications. From rebate distribution rules to state-level legislation, benefits managers should take note of key updates that may affect plan operations and documentation heading into year-end.